The global targeted therapeutics market size is expected to reach USD 162.89 Billion and register a revenue CAGR of 7.1% over the forecast period, according to latest analysis by Emergen Research. Steady market revenue growth can be attributed to increasing prevalence of different cancers. Various drugs for chemotherapy are incapable of differentiating between healthy and cancer cells, and thus can kill both kinds of cells. Targeted therapeutics, on the other hand, is a cancer treatment that makes use of drugs to target the exact proteins and genes that support survival and growth of cancer cells. Using targeted therapeutics, doctors influence the tissue environment that aids the spread of cancer or target cells associated with growth of cancer such as blood vessel cells. Also, targeted therapeutics is frequently used in combination with chemotherapy and other treatments. Over the years, various targeted therapies have been sanctioned by the US Food and Drug Administration, owing to growing prevalence of various kinds of cancers.

Cancer risk rises rapidly with age and it has been found that around 60?ses of cancers are diagnosed in individuals in the age group of 65 years or above. Considering the rising prevalence of cancer among an increasing geriatric population, specialized approaches such as targeted therapeutics are essential for diagnosis and treatment of geriatric patients suffering from cancer. Numerous medically intricate cases of metastatic renal cell carcinoma in geriatrics exhibited survival benefits using targeted therapeutic treatment.

The Global Targeted Therapeutics Market report is a detailed study of the different segments of the market, factors driving and restraining the growth of the market, and regional landscape based on the data gathered from both primary and secondary sources of data collection, along with the research methodology employed for analysis provided in the study. The market overview, SWOT analysis, and insights into the strategies adopted by key players operating in the Targeted Therapeutics market help understand the market forces and how those can be exploited to benefit from future opportunities.

Request To Download Sample of This Strategic Report At https://www.emergenresearch.com/request-sample/842

Some Key Highlights From the Report

In July 2021, Bicycle Therapeutics PLC, which is a biotechnology firm engaged in development of innovative and differentiated therapeutics class on the basis of its proprietary bicyclic peptide technology called Bicycle, made an announcement about entering into a global collaboration and license contract with Ionis Pharmaceuticals for tissue-targeted delivery of oligonucleotide therapeutics deploying Bicycles with high affinity to transferrin receptor (TfR1).

Among the therapy segments, monoclonal antibodies segment revenue is expected to account for a significantly robust revenue share over the forecast period. Monoclonal antibodies delivering cytotoxic molecules are capable of precisely killing cancer cells. Antibody, after being bound to its target cell, releases toxic molecule, including a poisonous chemical or radioactive substance that is taken up by the target cell and eventually destroys that cell. These toxins do not affect cells devoid of the antibody target. Examples of monoclonal antibody comprise trastuzumab (certain breast cancers), alemtuzumab (certain chronic leukemias), and cetuximab (certain colorectal, head, lung, and neck cancers).

Prostate cancer is the second-most cause of cancer deaths among men in the US. Currently used radiation therapy and prostatectomy are often supplemented with hormonal therapies for prostate cancer treatment. Also, in case of prostate cancer, recurrence is common, and many patients develop metastatic prostate cancer where chemotherapy is moderately effective and required targeted therapeutics after initial therapies.

The report focuses on mergers and acquisitions, joint ventures, collaborations, partnerships, corporate and government deals, and others. The report also talks about the expansions these prominent players are vying for in the key regions of the market. The report focuses on the detailed analysis of the technological and product developments undertaken by these companies.

In market segmentation by manufacturers, the report covers the following companies-
Amgen Inc., Genentech Inc., Arcus Biosciences Inc., Gilead Sciences Inc., AstraZeneca PLC, Serina Therapeutics Inc., F. Hoffmann-La Roche & Co., Agenus Inc., Pfizer Inc., and Aurinia Pharmaceutical Inc.

The research study gives a comprehensive analysis of the market with the help of several analytical tools and helps identify and capitalize on the growth prospects existing in the Targeted Therapeutics Market. It also offers accurate insights into the prevalent business strategies. The market overview gives growth estimations based on historical analysis and a detailed evaluation of the gross revenue, demand and supply dynamics, volume, market share, pricing structure, and profit margin for each market segment. The regional analysis takes into consideration the overall sales and CAGR to underline the leading companies in each regional Targeted Therapeutics based on product types and product applications.

Emergen Research has segmented global targeted therapeutics market on the basis of therapy, disease indication, end-use, and region:

Therapy Outlook (Revenue, USD Billion; 2018–2028)

Monoclonal Antibodies

Small Molecule Inhibitors

Disease Indication Outlook (Revenue, USD Billion; 2018–2028)

Lung Cancer

Breast Cancer

Colorectal Cancer

Prostate Cancer

Leukemia

Lymphoma

Multiple Sclerosis

Melanoma

Others

End-use Outlook (Revenue, USD Billion; 2018–2028)

Hospitals

Cancer Treatment Centers

Research Institutes

Others

Click here to Get [email protected] https://www.emergenresearch.com/purchase-enquiry/842

The report offers three types of Targeted Therapeuticss and uses analytical tools like Porter’s Five Forces analysis, SWOT analysis, and both qualitative and quantitative assessment of the market. It estimates the market size in the forecast duration by studying its value, volume, market share, growth rate, and other market essentials. It gives extensive company profiles, wherein the analysts explain the expansion tactics adopted by market leaders, including both long- and short-term strategies, and other vital competitive factors of significant businesses in the global Targeted Therapeutics market.

The report provides an in-depth study of the product, application, and regional segments of the global nano- and micro-satellite industry. As part of the regional analysis, the report includes an assessment of the leading regions of North America, Europe, India, China, and the EMEA.

Research Objectives:

It evaluates a comprehensive structure and overview of the Targeted Therapeutics Industry.

It provides accurate insights into critical factors like drivers and constraints, growth rate, value, volume, market share, and overall revenue.

It studies the growth prospects, challenges, drivers and restraints operating in the market.

It allows the reader to understand the Targeted Therapeutics market competition by assessing the top vendors, with elaborate company profiles, gross revenue, profit margin, import-export status, and global market share.

It brings to light the pricing structure, demand and supply dynamics, value chain analysis, SWOT analysis to support the formulation of lucrative business strategies.

It lists the data sources referred to during the study, detailed research methodology and other vital findings.

View Exhaustive Market Research Report @ https://www.emergenresearch.com/industry-report/targeted-therapeutics-market

The Targeted Therapeutics Market report also includes an investment analysis and growth trend analysis to help readers maximize their return on investment. It highlights the growth opportunities existing in the global Targeted Therapeutics market segments. It offers an extensive investigation of the import-export status and the rates of production and consumption. The Targeted Therapeutics Market report also provides some of the essential market aspects to draw a forecast for the coming years based on the information derived as part of the historical analysis and an analysis of the current market scenario.

Latest Published Reports by Emergen Research

Human Capital Management Market Growth https://www.emergenresearch.com/industry-report/human-capital-management-market

Technical Insulation Market Overview https://www.emergenresearch.com/industry-report/technical-insulation-market

Electronic Medical Records Market Analysis https://www.emergenresearch.com/industry-report/electronic-medical-records-market

Business Intelligence and Analytics Market https://www.emergenresearch.com/industry-report/business-intelligence-and-analytics-market

About Us:

At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Tags: Targeted Therapeutics Market, Targeted Therapeutics, Targeted Therapeutics Size

See Campaign: https://www.emergenresearch.com/industry-report/targeted-therapeutics-market

Contact Information:

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: [email protected]

Visit for More Insights: https://www.emergenresearch.com/insights

Explore Our Custom Intelligence services | Growth Consulting Services

 

Tags:
Reportedtimes, PR-Wirein, iCN Internal Distribution, Research Newswire, English